APOE and Alzheimer disease: Notably, the presence of LBD pathology was significantly associated with increasing age only in APOE ε4 carriers, reinforcing prior findings that APOE ε4 may modulate synucleinopathy-related processes in a manner distinct from its role in AD pathology [45, 46].